CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $62 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 76 cents per share.

The results fell short of Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.

The genome editing company posted revenue of $1.1 million in the period, which also missed Street forecasts. Six analysts surveyed by Zacks expected $11.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT